Dr. Kenneth Azuka Okpor M.D.

Recommended Articles

• Coping with COPD

  Many people live life without realizing that they have COPD – the umbrella term for emphysema and bronchitis – even though it is a common disease.Long-term smokers will most likely have scars on their lungs that will become inflamed and irritated due to COPD. Patients tend to complain, but fail...

• What Is Emphysema? Home Remedies for Emphysema Patients

  Emphysema is a form of chronic lung disease and one of the main types of chronic obstructive pulmonary disease (COPD). This disease is regarded as "obstructive" because people who are suffering from emphysema exhale air as if there is an obstruction. There are various factors that can cause...

• Everything You Need to Know About Aspiration Pneumonia

  Aspiration pneumonia or inhalation pneumonia is the inflammation of the lungs that occurs as a result of inhalation of various substances. These substances include vomit, food, foreign bodies, and regurgitated gastric juices.Aspiration of foreign objects can cause inflammation of the lungs,...

• What Are the Common Lung Irritants Found at Home?

  Traffic exhaust or second hand smoke are sure to trigger a number of lung issues, particularly if you are susceptible to respiratory disorders. However, there are a number of very common, yet hidden, triggers in one's household that can lead to symptoms of asthma and other respiratory ailments.There...

• How to Avoid Germs as Someone with CF

  Living with cystic fibrosis or CF can weigh heavily on your everyday routine. With the amount of medications and treatments that you constantly need to take, you are at a greater risk of catching germs and developing infections. Such infections can cause harm to your lungs, in turn leading to severe...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...